Immunization News and Research

RSS

Takeda brings innovative pipeline portfolio to patients for sustained revenue growth

As part of its Wave 1 Pipeline Market Opportunity Call, Takeda Pharmaceutical Company Limited provided an update on its pipeline portfolio, which has the potential to contribute significantly to revenue growth for the company over the next decade.

From Takeda 10 Dec 2020

Interim analysis of phase 3 study shows excellent efficacy of SARS-CoV-2 vaccine

South African study data were used to evaluate the safety of the vaccine in the results just published, but not its efficacy [which refers to the percentage reduction of disease].

9 Dec 2020

Interim results show Oxford COVID-19 vaccine protects against symptomatic disease

First full results from interim analysis confirm that the Oxford COVID-19 vaccine (AZD1222) has an acceptable safety profile and is efficacious against symptomatic COVID-19 disease, with no hospitalizations or severe disease reported in the COVID-19 vaccine group so far.

9 Dec 2020

UCI researchers develop new technology to rapidly hypermutate antibodies

Using the same strain of yeast that ferments wine and makes dough rise, a team led by University of California, Irvine and Harvard Medical School researchers has developed an in vitro technology that can rapidly hypermutate antibodies.

8 Dec 2020

The intranasal route of immunization may offer effective protection against SARS-CoV-2

Researchers at the School of Medicine, Washington University in Saint Louis, USA, showed that the intranasal route of immunization could provide a more efficient protection against SARS-CoV-2 compared to the intramuscular route (i.e. through ‘jabs’).

7 Dec 2020

Researchers urge policymakers to prioritize people with diabetes for COVID-19 vaccination

Vanderbilt University Medical Center researchers have discovered individuals with type 1 and type 2 diabetes infected with COVID-19 are three times more likely to have a severe illness or require hospitalization compared with people without diabetes.

5 Dec 2020

Vaccination against tuberculosis has influence on the epidemiology of COVID-19

St Petersburg University scientists have analyzed about 100 academic papers and statistics on the incidence of COVID-19 in different countries of the world.

3 Dec 2020

Come for your eye exam, leave with a band-aid on your arm

With multiple COVID-19 vaccines rapidly heading toward approval, optometrists and dentists are pushing for the authority to immunize patients during routine eye exams and dental cleanings.

3 Dec 2020

Feds look to pharmacists to boost childhood immunization rates

Torey Watson is trained as a pharmacist but aims to do more than simply fill prescriptions.

3 Dec 2020

CUNY SPH launches new initiative to address public concerns about COVID-19 vaccines

The City University of New York Graduate School of Public Health and Health Policy (CUNY SPH) today launched CONVINCE USAsm, part of a global project to increase understanding of factors that influence people's willingness to accept new COVID-19 vaccines, and to promote inclusive public dialogue to reduce vaccine hesitancy.

3 Dec 2020

Immune system differences, better blood vessel health could protect children from severe COVID-19

Differences in the immune systems and better blood vessel health were among the factors protecting children from severe COVID-19, according to a new review.

2 Dec 2020

The UK approves Pfizer vaccine for December 2020 roll out

The UK approves Pfizer vaccine and schedules phased vaccination process, commencing December 2020.

2 Dec 2020

UTHSC receives $1.25 million to conduct a study on improving adherence to HPV vaccine

The human papillomavirus (HPV) vaccine was introduced in the United States for preteens more than a dozen years ago, yet adherence rates are still below those for other childhood vaccines.

2 Dec 2020

What are the risks associated with human challenge trials for SARS-CoV-2 vaccine candidates?

Researchers from the University of Haifa, Israel, and WAW Statistical Consulting Ltd, UK, designed a model that helps determine the risks faced by participants in a hypothetical COVID-19 dosing study.

30 Nov 2020

COVID-19 Peer Hub program works to tackle vaccine hesitancy amid pandemic

UniSA researchers are evaluating a new vaccination education initiative - the COVID-19 Peer Hub - to help immunization and public health professionals to tackle the emerging dangers of vaccine hesitancy amid the pandemic.

30 Nov 2020

Siemens Healthineers SARS-CoV-2 IgG antibody test demonstrates ability to detect neutralizing antibodies

Siemens Healthineers has announced its SARS-CoV-2 IgG Antibody Test has proven to measure neutralizing antibodies and has achieved CE Mark. The test is an enhanced version of the assay which became available globally this summer.

From Siemens Healthineers 27 Nov 2020

Convalescent plasma therapy ineffective in treating severe COVID-19, study finds

A recent study based at a hospital in Buenos Aires, Argentina, found that convalescent plasma therapy for patients with severe COVID-19, and COVID-19-related pneumonia, was largely ineffective.

25 Nov 2020

The American Lung Association say to wear masks to stop the spread of COVID-19; Here’s why

Dr. Albert Rizzo speaks to News-Medical about the importance of wearing masks to help control the spread of COVID-19.

25 Nov 2020

Mauritian Prime Minister calls upon world leaders to ensure fair distribution of Covid-19 vaccines

Mauritian Prime Minister Pravind Jugnauth calls for Covid-19 vaccines to be ‘distributed fairly’ amid fears that some parts of the world might be left behind in the dash for coronavirus immunity.

24 Nov 2020

New technology can provide immunization against infectious diseases

A single-use, self-administered microneedle technology developed by UConn faculty to provide immunization against infectious diseases has recently been validated by preclinical research trials.

23 Nov 2020

Immunization News and Research

Takeda brings innovative pipeline portfolio to patients for sustained revenue growth

Interim analysis of phase 3 study shows excellent efficacy of SARS-CoV-2 vaccine

Interim results show Oxford COVID-19 vaccine protects against symptomatic disease

UCI researchers develop new technology to rapidly hypermutate antibodies

The intranasal route of immunization may offer effective protection against SARS-CoV-2

Researchers urge policymakers to prioritize people with diabetes for COVID-19 vaccination

Vaccination against tuberculosis has influence on the epidemiology of COVID-19

Come for your eye exam, leave with a band-aid on your arm

Feds look to pharmacists to boost childhood immunization rates

CUNY SPH launches new initiative to address public concerns about COVID-19 vaccines

Immune system differences, better blood vessel health could protect children from severe COVID-19

The UK approves Pfizer vaccine for December 2020 roll out

UTHSC receives $1.25 million to conduct a study on improving adherence to HPV vaccine

What are the risks associated with human challenge trials for SARS-CoV-2 vaccine candidates?

COVID-19 Peer Hub program works to tackle vaccine hesitancy amid pandemic

Siemens Healthineers SARS-CoV-2 IgG antibody test demonstrates ability to detect neutralizing antibodies

Convalescent plasma therapy ineffective in treating severe COVID-19, study finds

The American Lung Association say to wear masks to stop the spread of COVID-19; Here’s why

Mauritian Prime Minister calls upon world leaders to ensure fair distribution of Covid-19 vaccines

New technology can provide immunization against infectious diseases

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News